Annual SG&A
$26.91 M
-$9.28 M-25.65%
31 December 2023
Summary:
Finch Therapeutics annual selling, general & administrative expenses is currently $26.91 million, with the most recent change of -$9.28 million (-25.65%) on 31 December 2023. During the last 3 years, it has risen by +$12.90 million (+92.06%). FNCH annual SG&A is now -25.65% below its all-time high of $36.19 million, reached on 31 December 2022.FNCH Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$6.11 M
+$945.00 K+18.30%
30 June 2024
Summary:
Finch Therapeutics quarterly selling, general & administrative expenses is currently $6.11 million, with the most recent change of +$945.00 thousand (+18.30%) on 30 June 2024. Over the past year, it has increased by +$2.37 million (+63.56%). FNCH quarterly SG&A is now -36.48% below its all-time high of $9.62 million, reached on 31 March 2023.FNCH Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$1.41 B
-$14.17 M-1.01%
30 June 2024
Summary:
Finch Therapeutics TTM selling, general & administrative expenses is currently -$1.41 billion, with the most recent change of -$14.17 million (-1.01%) on 30 June 2024. Over the past year, it has dropped by -$1.44 billion (-4612.86%). FNCH TTM SG&A is now -1272.22% below its all-time high of $37.12 million, reached on 30 June 2023.FNCH TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FNCH Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -25.6% | +63.6% | -4612.9% |
| 3 y3 years | +92.1% | +6.5% | -6359.1% |
| 5 y5 years | - | - | - |
FNCH Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -25.6% | +92.1% | -36.5% | +63.6% | -185.9% | at low |
| 5 y | 5 years | -25.6% | +261.7% | -36.5% | +170.6% | -1272.2% | at low |
| alltime | all time | -25.6% | +261.7% | -36.5% | +170.6% | -1272.2% | at low |
Finch Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | - | $6.11 M(+18.3%) | $19.69 M(-12.3%) |
| Mar 2024 | - | $5.16 M(+10.3%) | $22.46 M(-16.5%) |
| Dec 2023 | $26.91 M(-25.6%) | $4.68 M(+25.3%) | $26.91 M(-13.9%) |
| Sept 2023 | - | $3.73 M(-57.9%) | $31.27 M(-15.8%) |
| June 2023 | - | $8.88 M(-7.7%) | $37.12 M(+2.0%) |
| Mar 2023 | - | $9.62 M(+6.4%) | $36.41 M(+0.6%) |
| Dec 2022 | $36.19 M | $9.04 M(-5.7%) | $36.19 M(+12.3%) |
| Sept 2022 | - | $9.58 M(+17.4%) | $32.22 M(+13.6%) |
| June 2022 | - | $8.16 M(-13.2%) | $28.37 M(+8.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $9.40 M(+85.7%) | $26.09 M(+22.8%) |
| Dec 2021 | $21.24 M(+51.6%) | $5.07 M(-11.7%) | $21.24 M(-5.8%) |
| Sept 2021 | - | $5.74 M(-2.4%) | $22.55 M(+14.9%) |
| June 2021 | - | $5.88 M(+29.2%) | $19.61 M(+20.3%) |
| Mar 2021 | - | $4.55 M(-28.6%) | $16.30 M(+16.4%) |
| Dec 2020 | $14.01 M(+88.3%) | $6.37 M(+127.0%) | $14.01 M(+83.4%) |
| Sept 2020 | - | $2.81 M(+9.1%) | $7.64 M(+58.1%) |
| June 2020 | - | $2.57 M(+14.0%) | $4.83 M(+114.0%) |
| Mar 2020 | - | $2.26 M | $2.26 M |
| Dec 2019 | $7.44 M | - | - |
FAQ
- What is Finch Therapeutics annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Finch Therapeutics?
- What is Finch Therapeutics annual SG&A year-on-year change?
- What is Finch Therapeutics quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Finch Therapeutics?
- What is Finch Therapeutics quarterly SG&A year-on-year change?
- What is Finch Therapeutics TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Finch Therapeutics?
- What is Finch Therapeutics TTM SG&A year-on-year change?
What is Finch Therapeutics annual selling, general & administrative expenses?
The current annual SG&A of FNCH is $26.91 M
What is the all time high annual SG&A for Finch Therapeutics?
Finch Therapeutics all-time high annual selling, general & administrative expenses is $36.19 M
What is Finch Therapeutics annual SG&A year-on-year change?
Over the past year, FNCH annual selling, general & administrative expenses has changed by -$9.28 M (-25.65%)
What is Finch Therapeutics quarterly selling, general & administrative expenses?
The current quarterly SG&A of FNCH is $6.11 M
What is the all time high quarterly SG&A for Finch Therapeutics?
Finch Therapeutics all-time high quarterly selling, general & administrative expenses is $9.62 M
What is Finch Therapeutics quarterly SG&A year-on-year change?
Over the past year, FNCH quarterly selling, general & administrative expenses has changed by +$2.37 M (+63.56%)
What is Finch Therapeutics TTM selling, general & administrative expenses?
The current TTM SG&A of FNCH is -$1.41 B
What is the all time high TTM SG&A for Finch Therapeutics?
Finch Therapeutics all-time high TTM selling, general & administrative expenses is $37.12 M
What is Finch Therapeutics TTM SG&A year-on-year change?
Over the past year, FNCH TTM selling, general & administrative expenses has changed by -$1.44 B (-4612.86%)